CURX Stock Summary and Trading Ideas (Curanex Pharmaceuticals | NASDAQ:CURX)

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.

What symbol and exchange does Curanex Pharmaceuticals shares trade?

Curanex Pharmaceuticals trades on the NASDAQ stock market under the symbol CURX.

What is Curanex Pharmaceuticals stock price doing today?

As of August 21, 2026, CURX stock price declined to $4.71 with 23,815 million shares trading.

What is Curanex Pharmaceuticals's Beta?

CURX has a beta of -0.27, meaning it tends to be less sensitive to market movements. CURX has a correlation of 0.00 to the broad based SPY ETF.

How much is Curanex Pharmaceuticals worth?

CURX has a market cap of $7.39 million. This is considered a Sub-Micro Cap stock.

What are the support and resistance levels for Curanex Pharmaceuticals (CURX)?

CURX support price is $4.84 and resistance is $5.70 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CURX shares will trade within this expected range on the day.